Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2022-05-12

Clinical Trial Update: Dose-finding Study of Colchicine in Type 2 Diabetic Patients With Coronary Artery Disease [Phase 2]

View source ↗

Summary

Phase 2 dose-finding study of colchicine in Type 2 diabetes patients with coronary artery disease completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • COLCHICINE (Colchicine)

Snippet

Sponsor: University of the Ryukyus | Conditions: Colchicine, Diabetes Mellitus, Type 2 | Phase 2 | Status: COMPLETED